French Guiana vs Lithuania: Cancer death rate by age group
French Guiana
0 deaths per 100,000 people
in 2016
Lithuania
0 deaths per 100,000 people
in 2023
French Guiana rank
77th
Lithuania rank
77th
Cancer death rate by age group over time
- French Guiana
- Lithuania
How they compare
French Guiana currently reports 0 deaths per 100,000 people against 0 deaths per 100,000 people in Lithuania, a difference of 0 deaths per 100,000 people.
The two have swapped places 2 times across 16 shared years of data; in 2001 it was Lithuania ahead.
French Guiana ranks 77th and Lithuania ranks 77th of 111 countries.
Lithuania has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | French Guiana | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.99 deaths per 100,000 people | 4.09 deaths per 100,000 people | 2.1 deaths per 100,000 people | Lithuania |
| 2010s | 0 deaths per 100,000 people | 3.26 deaths per 100,000 people | 3.26 deaths per 100,000 people | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rate by age group, French Guiana or Lithuania?
- French Guiana, at 0 deaths per 100,000 people against 0 deaths per 100,000 people in Lithuania as of 2016.
- What is the difference in cancer death rate by age group between French Guiana and Lithuania?
- 0 deaths per 100,000 people, with French Guiana ahead.
- How many years of comparable data are there for French Guiana and Lithuania?
- 16 years are reported by both, from 2001 to 2016.
- How do French Guiana and Lithuania rank globally for cancer death rate by age group?
- French Guiana ranks 77th and Lithuania ranks 77th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) β with minor processing by Our World in Data, published as Cancer death rate by age group. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged less than 1 year.